In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras Mutant Lung Adenocarcinoma. Breadcrumbs UL Home Research Publications Year of Publication 2019 Journal Cancer Discovery DOI 10.1158/2159-8290.cd-19-0780
